• 1. Department of Health Science, National Natural Science Foundation of China, Beijing 100085, P. R. China;
  • 2. Department of Cardiology, Yangpu Hospital, Tongji University, Shanghai 200090, P. R. China;
  • 3. Department of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P. R. China;
  • 4. Department of Respiratory and Critical Care Medicine, Subei People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu 225001, P. R. China;
  • 5. Department of Hematology, First Affiliated Hospital of University of South China, Hengyang, Hunan 421800, P. R. China;
JIANG Hujun, Email: jianghj@nsfc.gov.cn
Export PDF Favorites Scan Get Citation

Objective To understand the current situation and challenges of basic research on respiratory diseases in China.Methods To summarize and analyze the application and projects funded in the field of respiratory medicine (Code: H01 and H1615) from National Natural Science Foundation of China (NSFC) during 2010 to 2017.Results A total of 2 191 projects of 11 766 applications were funded by NSFC in the field of respiratory medicine and the total subsidy fund reached ¥981 279 000. A total of 1 130 projects of 5 915 applications were funded in the Research Projects, including 1 021 General Program projects, 14 Key Program projects, 16 Major Research Plan projects, 1 Major Research Program project, 2 Program projects of Joint Funds, 30 International (Regional) Cooperation and Exchange Program projects, and 46 Emergency Management Program projects. A total of 1 061 projects of 5 851 applications were funded in the Talent Projects, including 853 Young Scientists Fund projects, 191 projects of Fund for Less Developed Regions, 4 projects of Distinguished Young Scholars, 4 projects of Excellent Young Scientists Fund, and 9 projects of the Research Fund for International Young Scientists. The projects funded were mainly distributed in the field of respiratory inflammation and infection, asthma, chronic obstructive pulmonary disease, pulmonary circulation and pulmonary vascular disease. The top three research directions were asthma (19.0%), acute lung injury and acute respiratory distress syndrome (15.4%), chronic obstructive pulmonary disease (12.7%), pulmonary circulation and pulmonary vascular disease (12.7%) in sequence. Average funding rate of respiratory tumor (application code: H1615) was 17.2%.Conclusions Since the Department of Health Science of NSFC was established in 2009, with the increasing of NSFC budget, the basic research in the field of Respiratory Medicine has been developed rapidly. With the efforts of scientific researchers and clinical medical workers, research in the field of respiratory medicine will achieve rapid development in China.

Citation: WANG Rui, YANG Liming, MIN Lingfeng, ZHANG Ji, ZHU Yuangui, JIANG Hujun. Analysis of project application and funding by National Natural Science Foundation of China in the field of respiratory medicine from 2010 to 2017. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(4): 377-383. doi: 10.7507/1671-6205.201809056 Copy

  • Previous Article

    The effect of direct coagulation factor Xa inhibitor on acute lung injury progression induced by endotoxin in mice
  • Next Article

    Kartagener 综合征四例报告并文献复习